International Biotechnology Trust plc

(the "Company")

Appointment of Non-Executive Director

The Board of International Biotechnology Trust plc is pleased to announce the appointment of Alexa Henderson as an independent Non-Executive Director of the Company with effect from 1 January 2025.

Alexa will succeed Caroline Gulliver as Chair of the Company's Audit Committee. In line with Alexa's date of appointment it is now intended that Caroline Gulliver, who has served nine years on the Board, will stand for re-election at the Company's 2024 Annual General Meeting, and remain on the Board for a short period to ensure a smooth transition. On appointment, Alexa will also join the Management Engagement Committee and Nomination Committee.

Alexa has over 30 years' experience in finance, accounting and audit having worked at KPMG, Arthur Andersen and Deutsche Bank (WM Company). Alexa is currently Chair of JPMorgan Japan Small Cap Growth and Income plc (anticipated to retire in October 2024), and a non- executive director of abrdn UK Smaller Companies Growth Trust plc and WAM Leaders Limited, an Australian listed investment company. Previous directorships include Scottish Building society (which she chaired for four years), CT Property Trust Limited, Bravura Solutions Limited and Adam & Company Group PLC. Alexa holds a BSc in Accounting and Economics from Edinburgh University and is a Chartered Accountant.

The Company's Chair, Kate Cornish-Bowden, said "We are delighted to welcome Alexa to the Board. She brings with her extensive global experience chairing audit committees for a number of financial institutions including investment trusts."

In accordance with paragraph 6.4.8 of the Listing Rules, it is confirmed that there are no further details to be disclosed in relation to Alexa Henderson.

Enquiries:

Schroder Investment Management Limited

Kerry Higgins

Tel: 0207 658 6000